GlucoTrack, Inc. (GCTK)
GCTK moved a median of -0.87% 30 minutes after news, and -0.56% by the close. How GCTK actually reacts to news — the realized, point-in-time move the market made, measured across 273 labeled events over the last three years with zero look-ahead.
GCTK’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 37% | 249 |
| 30-min | -0.87% | 36% | 265 |
| 60-min | -0.76% | 42% | 272 |
| to close | -0.56% | 44% | 272 |
| Middle 50% of GCTK reactions | -4.11% to +1.33% |
|---|---|
| Median reaction (30-min) | -0.87% |
| Measured reactions | 273 |
Half of all GlucoTrack, Inc. news events land between -4.11% and +1.33% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GCTK moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GCTK's baseline. Nothing else.
Recent GCTK events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form PRE 14A Glucotrack, Inc. For: Oct 13 | SEC filing · Form PRE | SEC EDGAR | +0.02% | -16.22% | |
| Form S-1/A Glucotrack, Inc. | SEC filing · Form S-1 | SEC EDGAR | -2.73% | -19.34% | |
| Qare™ Is Here: Lokahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications | Press release | Business Wire | -2.73% | -19.34% | |
| Form 8-K/A Glucotrack, Inc. For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | -2.73% | -19.34% | |
| Lokahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn | Press release | Business Wire | -2.98% | -9.70% | |
| Lokahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14 | Press release | Business Wire | -2.79% | -8.38% | |
| Form 8-K Glucotrack, Inc. For: Sep 22 | SEC filing · Form 8-K | SEC EDGAR | -4.00% | +1.16% | |
| Lokahi Therapeutics™ Expands ai² Pipeline™ Program Through Collaboration with Pepperdine E2B™ | Press release | Business Wire | +0.01% | -20.87% | |
| Form 8-K Glucotrack, Inc. For: Sep 24 | SEC filing · Form 8-K | SEC EDGAR | +0.01% | -20.87% | |
| Glucotrack, Inc. Announces Pricing of $3 Million Public Offering | Press release | Business Wire | +11.73% | +4.03% | |
| Form 8-K Glucotrack, Inc. For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | -0.90% | -8.97% | |
| Lokahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform | Press release | Business Wire | +11.73% | +4.03% | |
| Lokahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities | Press release | Business Wire | -0.90% | -8.97% | |
| Form 8-K Glucotrack, Inc. For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -8.37% | |
| Form S-1 Glucotrack, Inc. | SEC filing · Form S-1 | SEC EDGAR | +0.00% | +3.35% | |
| Lokahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent | Press release | Business Wire | +0.00% | +3.35% | |
| Form 8-K Glucotrack, Inc. For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -5.81% | |
| Form 8-K Glucotrack, Inc. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | -1.60% | -2.00% | |
| Glucotrack Announces $11.5 Million Financing | Press release | Business Wire | -3.60% | -16.67% | |
| Form 8-K Glucotrack, Inc. For: Sep 04 | SEC filing · Form 8-K | SEC EDGAR | +1.97% | +6.25% | |
| Lokahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions | Press release | Business Wire | -0.33% | -3.30% | |
| Lokahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business | Press release | Business Wire | +11.61% | +1.15% | |
| Form 8-K Glucotrack, Inc. For: Aug 28 | SEC filing · Form 8-K | SEC EDGAR | -2.14% | +1.19% | |
| Form 8-K/A Glucotrack, Inc. For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | -2.14% | +1.19% | |
| Form 8-K Glucotrack, Inc. For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | -2.51% | -14.52% | |
| Glucotrack, Inc. Announces Reverse Stock Split | Press release | Business Wire | -2.51% | -14.52% | |
| Lokahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 | Press release | Business Wire | -1.91% | +0.06% | |
| Form DEFA14A Glucotrack, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.39% | -1.36% | |
| Lokahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia | Press release | Business Wire | +3.58% | +2.84% | |
| Form 8-K Glucotrack, Inc. For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | +2.41% | +5.12% | |
| Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation | Press release | Business Wire | -5.77% | -12.33% | |
| Form 10-Q Glucotrack, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.77% | -12.33% | |
| Form DEF 14A Glucotrack, Inc. For: Aug 10 | SEC filing · Form DEF | SEC EDGAR | +1.52% | -5.67% | |
| E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack | Press release | GlobeNewswire | -3.31% | -9.12% | |
| Form 8-K Glucotrack, Inc. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | -3.31% | -9.12% | |
| Glucotrack Announces $5.5 Million Financing | Press release | Business Wire | -0.37% | +2.32% | |
| Form PRE 14A Glucotrack, Inc. For: Jul 31 | SEC filing · Form PRE | SEC EDGAR | -1.75% | -18.49% | |
| Lokahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline | Press release | Business Wire | +8.38% | -14.55% | |
| Form 8-K Glucotrack, Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +8.38% | -14.55% | |
| Form 8-K/A Glucotrack, Inc. For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | -8.38% | +91.13% | |
| Lokahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration | Press release | Business Wire | -8.38% | +91.13% | |
| Form 8-K Glucotrack, Inc. For: Jul 22 | SEC filing · Form 8-K | SEC EDGAR | -1.66% | -0.33% | |
| E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lokahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing | Press release | GlobeNewswire | +0.14% | -2.15% | |
| Form ARS Glucotrack, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.28% | -5.83% | |
| Form DEF 14A Glucotrack, Inc. For: Jul 17 | SEC filing · Form DEF | SEC EDGAR | -0.28% | -5.83% | |
| Glucotrack, Inc. and Lokahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives | Press release | GlobeNewswire | -0.14% | -5.17% | |
| UPDATE – Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | Press release | GlobeNewswire | -0.14% | -5.17% | |
| Form 8-K Glucotrack, Inc. For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | -0.35% | +3.78% | |
| Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | Press release | GlobeNewswire | -7.65% | -11.83% | |
| Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform | Press release | GlobeNewswire | -0.99% | +6.12% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GCTK section they belong to.
Where else GCTK is measured.
GCTK earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is GlucoTrack, Inc.'s median reaction calculated?
Every labeled GCTK news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 273 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 36% of GCTK's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GCTK's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.